Abstract

There is rising use of recreational nitrous oxide (N₂O) in the community because of its availability as “whippet” canisters. Nitrous oxide use is still legal and outside the purview of the Drug Enforcement Administration (DEA). It is not detected on a routine drug screen, and patient history is key to establishing the diagnosis. We highlight a case of subacute combined degeneration in a young patient secondary to recreational nitrous oxide use, which improved with vitamin B12 replacement. A 19-year-old male with a history of recreational nitrous oxide use presented with progressive bilateral lower extremity paresthesia and ataxia. Neurological examination revealed deficits in vibration and proprioception, motor weakness, and diminished reflexes in the bilateral lower extremities. The laboratory results were significant for pancytopenia, profound vitamin B12 deficiency (55 ng/mL), and elevated methylmalonic acid (2.14 umol/L). The urine drug screen was negative. MRI showed subacute degeneration of the spinal cord dorsal column at C2-C5. Treatment with intramuscular cyanocobalamin resulted in the normalization of pancytopenia and B12 levels (573 ng/mL). The patient had partial resolution of neurological symptoms following the initiation of parenteral vitamin B12 replacement. The mechanism of subacute combined degeneration in the setting of nitrous oxide toxicity appears to be mediated by functional B12 deficiency. Oxidation of cobalt ion of vitamin B12 by nitrous oxide renders it unavailable as a coenzyme, leading to the accumulation of by-products that enter lipid metabolism, resulting in abnormal myelin synthesis, which ultimately manifests as subacute combined degeneration. Vitamin B12 deficiency of unclear etiology should raise suspicion for nitrous oxide toxicity as early initiation of replacement therapy with vitamin B12 can improve neurological function.

Highlights

  • The recreational use of nitrous oxide (N2O) or laughing gas continues to increase in the community [1,2]

  • We present a case of myelopathy in a young patient secondary to recreational nitrous oxide use

  • We provided education and counseling regarding the adverse effects of nitrous oxide use, and the patient expressed motivation not to use nitrous oxide in the future

Read more

Summary

Introduction

The recreational use of nitrous oxide (N2O) or laughing gas continues to increase in the community [1,2]. It is a cheap, readily available, euphoria-inducing agent undetectable on routine drug screens. We present a case of myelopathy in a young patient secondary to recreational nitrous oxide use. The patient admitted to inhaling 100-150 nitrous oxide cartridges weekly for the past year for recreational use. Neurological examination revealed mild motor weakness (4/5), deficits in vibration and proprioception sensation (in a length-dependent manner), and diminished deep tendon reflexes (1+) in bilateral lower extremities. Bilateral upper extremity showed normal strength, sensations, and reflexes. The patient had partial resolution of neurological symptoms during hospitalization, and he was discharged with a plan to continue outpatient physical rehabilitation

Discussion
Conclusions
Disclosures
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call